Spero Therapeutics SPRO
NASDAQ SPRO
$1.22 +0.01 (+0.83%)
At close: Aug 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2026)

Spero Therapeutics' (SPRO) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, down 7.04% YoY from $1.5 million in Q1 2025, and down 11.93% on a QoQ basis from $1.6 million in Q4 2025.

Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2026) Analysis & Trends

Spero Therapeutics (SPRO) has 11 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.

  • Quarterly Prepaid Assets fell 7.04% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 7.04% YoY) and the FY2025 annual result came in at $1.6 million, down 14.5% from the prior year.
  • Prepaid Assets slipped to $1.4 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.7 million in Q1 2022 to a low of $1.2 million in Q3 2025.
  • A 5-year average of $3.4 million and a median of $3.2 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets sank 74.2% — and 2023, when it soared 263.44%.
  • Tracing SPRO's Prepaid Assets over 5 years: stood at $3.4 million in 2022, then gained by 23.65% to $4.2 million in 2023, then sank by 54.26% to $1.9 million in 2024, then slipped by 14.5% to $1.6 million in 2025, then dropped by 11.93% to $1.4 million in 2026.
  • The last three Prepaid Assets figures came in at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Spero Therapeutics 70.72 Mn 19.95 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 785,000.00
Mar 31, 2026 1.44 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 3.67 Mn
Dec 31, 2023 4.18 Mn
Sep 30, 2023 5.41 Mn
Jun 30, 2023 8.57 Mn
Mar 31, 2023 3.54 Mn
Dec 31, 2022 3.38 Mn
Sep 30, 2022 1.49 Mn
Jun 30, 2022 4.98 Mn
Mar 31, 2022 8.75 Mn
Dec 31, 2021 8.83 Mn
Sep 30, 2021 5.77 Mn